StockData
Quantum-Si Inc logo

Quantum-Si Inc (QSI) company profile

QSINasdaqMeasuring & Controlling Devices, NECFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 7/30
$1.01−0.05 (-4.72%)

Close on Nov 17, 2026Market cap $221.07MP/E –Yield –

About Quantum-Si

Measuring & Controlling Devices, NEC, SIC 3829

Quantum-Si Incorporated is a life sciences company focused on proteomics research and single-molecule protein analysis. The company develops and commercializes next-generation protein sequencing platforms that enable massively parallel protein characterization at single-molecule resolution. Its primary product offerings include the Platinum and Platinum Pro benchtop sequencing instruments, cloud-based and on-instrument Platinum Analysis Software, and specialized consumables such as library preparation, barcoding, and semiconductor sequencing kits. The company serves researchers and clinicians across academic research institutions, biopharmaceutical companies, contract development and manufacturing organizations, government bodies, and industrial laboratories.

The company operates commercially through a direct sales team in the United States and uses a blend of direct sales and distributor arrangements across Europe. In addition, it maintains international distribution partnerships spanning multiple countries throughout the Middle East, Africa, Asia Pacific, and South America, alongside a North American distribution partnership with Avantor. The company is incorporated in Delaware, though its headquarters location is not specified in the text.

Summary of the business section of Quantum-Si's latest annual report, written by StockData.

Company profile

Company

Legal name
Quantum-Si Inc
Founded
2013
Headquarters
Branford, CT
Address
29 Business Park Drive 06405
Phone
(203) 458-7100
Employees
138, Dec 31, 2025
Industry
Measuring & Controlling Devices, NEC
Incorporated in
Delaware
Fiscal year ends
December 31
Auditor
Deloitte & Touche LLP, New York, New York

Stock & identifiers

Ticker
QSI
Former tickers
CAPA until Aug 16, 2021
Exchange
Nasdaq
IPO date
Sep 4, 2020
Shares outstanding
219M, Aug 11, 2026
Public float
$286.30M, Jun 30, 2025
Filer category
Non-accelerated filer<br>Smaller reporting company
Stock splits
41-for-3, May 10, 2022
SEC CIK
1816431
CUSIP
74765K105
ISIN
US74765K1051
FIGI
BBG00X8RS963
Share class FIGI
BBG00X8RS972
EIN
85-1388175

Executives and directors

Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years

NamePositionShares owned
Jeffrey Alan HawkinsPresident & CEO, Director3,639,950
Jeffry R. KeyesChief Financial Officer1,716,684
Christian LaPointeGC & Corp. Secretary1,167,913
John S. VieceliChief Product Officer1,140,434
Todd C. BennettChief Commercial Officer681,521
Kevin RakinDirector1,220,512
Brigid MakesDirector20,512
Amir JafriDirector115,942
Paula DowdyDirector269,107
Charles R. KummethDirector855,000
John P. KennyDirector114,285
Scott MendelDirector141,843
Ruth A. FattoriDirector170,512
Jonathan M. RothbergDirector33,644,178

CEO pay and shareholder return

Pay versus performance table from the proxy statement

Fiscal yearCEO total payCEO pay actually paidOther executives (avg)Value of $100 investedPeer group
FY2025$3.18M-$2.91M$1.56M$60–
FY2024$4.44M$8.72M$1.65M$148–
FY2023$1.05M$1.92M$1.35M$110–
FY2022
Jeffery Hawkins
$7.70M$6.12M$2.78M$23–
FY2022
John Stark
$816.00K-$10.09M$2.78M$23–
FY2022
Jonathan Rothberg
$501.67K-$8.70M$2.78M$23–

“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.

Executive compensation, fiscal 2025

Summary compensation table from the latest proxy statement

ExecutiveSalaryStock awardsIncentive payOtherTotalvs. prior year
Jeffrey Hawkins
President and Chief Executive Officer
$620.83K$2.00M$562.50K$360$3.18M-28%
Jeffry Keyes
Chief Financial Officer and Treasurer
$481.67K$900.00K$270.63K$4.55K$1.66M-18%
John Vieceli
Chief Product Officer
$411.67K$850.00K$192.98K$360$1.46M–

Stock and option awards are grant-date fair values, not realized pay. “Other” includes pension value changes and all other compensation. Source proxy statement.

IPO

From the final prospectus (Form 424B4) and the first day of trading

SPAC offering

Type
SPAC (blank check) IPO of units
Final prospectus filed
Sep 4, 2020
Offer price
$10.00
Securities offered
10,000,000
Gross proceeds
$100.00M
Exchange
Nasdaq
Lock-up ends (est.)
Mar 3, 2021

“Each unit has an offering price of $10.00 and consists of one share of Class A common stock and one-third of one redeemable warrant.”

Lock-up end is estimated as 180 days after the first trading day; the prospectus sets the actual terms.

Employees

Headcount reported in annual reports

“As of December 31, 2025 , we employed 138 full-time employees in the United States and 7 full-time employees internationally.”

Corporate history

Events identified from SEC filings

See a number that looks wrong?